A randomized phase III trial of postoperative adjuvant chemotherapy versus surgery alone for radically resected gastric cancer (GC):: Final results of 9602 GOIM study

被引：0
|
作者：
De Vita, F.
Giuliani, F.
Orditura, M.
Maiello, E.
Manzione, L.
Galizia, G.
Romito, S.
Gebbia, V
Carteni, G.
Catalano, G.
Colucci, G.
机构：
[1] Ist Oncol, Bari, Italy
[2] Univ Naples 2, Naples, Italy
[3] Casa Sollievo Sofferenza, SG Rotondo, Italy
[4] Osped Potenza, Potenza, Italy
[5] Univ Palermo, I-90133 Palermo, Italy
[6] AORN Cardarelli, Naples, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI54 / XI54
页数：1
相关论文
共 50 条
  • [21] Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer. First results of a randomized phase III trial EORTC 10901
    Paridaens, R.
    Dyczka, J.
    Rutgers, E. J. T.
    Coleman, R.
    Cufer, T.
    Jassem, J.
    Nortier, J. W. R.
    Morales, L.
    Mattiacci, M. R.
    Therasse, P.
    [J]. EJC SUPPLEMENTS, 2004, 2 (03): : 70 - 70
  • [22] An update on the randomized phase III POST trial: S-1 based doublet as an adjuvant chemotherapy for curatively resected stage III gastric cancer
    Lee, Choong-kun
    Jung, Minkyu
    Kim, Hyo Song
    Jung, Inkyung
    Shin, Dong Bok
    Kang, Seok Yun
    Zang, Dae Young
    Kim, Ki Hyang
    Lee, Moon Hee
    Kim, Bong-Seog
    Lee, Kyung Hee
    An, Ji Yeong
    Kim, Hyoung-Il
    Cheong, Jae-Ho
    Hyung, Woo Jin
    Noh, Sung Hoon
    Chung, Hyun Cheol
    Rha, Sun Young
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [23] Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 for patients with resected pancreatic cancer (JASPAC-01 study)
    Uesaka, Katsuhiko
    Fukutomi, Akira
    Boku, Narikazu
    Kanemoto, Hideyuki
    Konishi, Masaru
    Matsumoto, Ippei
    Kaneoka, Yuji
    Shimizu, Yasuhiro
    Nakamori, Shoji
    Sakamoto, Hirohiko
    Morinaga, Soichiro
    Kainuma, Osamu
    Imai, Koji
    Sata, Naohiro
    Hishinuma, Shoichi
    Nakamura, Takayuki
    Kanai, Michio
    Hirano, Satoshi
    Yoshikawa, Yukinobu
    Ohashi, Yasuo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [24] Adjuvant chemotherapy in resected gastric cancer (RGC): results and prognostic factors related to the risk of relapse. Phase III trial of GOIRC
    Gasperoni, Silvia
    Manzione, Luigi
    Tonato, Maurizio
    Bisagni, Giancarlo
    Bravi, Stefano
    Cortesi, Enrico
    Carlini, Paolo
    Floriani, Irene
    Labianca, Roberto
    Di Costanzo, Francesco
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 231 - 232
  • [25] JASPAC 01: Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 for patients with resected pancreatic cancer
    Fukutomi, Akira
    Uesaka, Katsuhiko
    Boku, Narikazu
    Kanemoto, Hideyuki
    Konishi, Masaru
    Matsumoto, Ippei
    Kaneoka, Yuji
    Shimizu, Yasuhiro
    Nakamori, Shoji
    Sakamoto, Hirohiko
    Morinaga, Soichiro
    Kainuma, Osamu
    Imai, Koji
    Sata, Naohiro
    Hishinuma, Shoichi
    Nakamura, Takayuki
    Kanai, Michio
    Hirano, Satoshi
    Yoshikawa, Yukinobu
    Ohashi, Yasuo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [26] Postoperative Adjuvant Therapy Versus Surgery Alone for Stage IIB-III Esophageal Squamous Cell Carcinoma: A Phase III Randomized Controlled Trial
    Ni, Wenjie
    Yu, Shufei
    Xiao, Zefen
    Zhou, Zongmei
    Chen, Dongfu
    Feng, Qinfu
    Liang, Jun
    Lv, Jima
    Gao, Shugeng
    Mao, Yousheng
    Xue, Qi
    Sun, Kelin
    Liu, Xiangyang
    Fang, Dekang
    Li, Jian
    Wang, Dali
    Zhao, Jun
    Gao, Yushun
    [J]. ONCOLOGIST, 2021, 26 (12): : E2151 - E2160
  • [27] Postoperative Adjuvant Chemoradiotherapy Versus Chemotherapy Alone for Stage III Endometrial Cancer: A Multicenter Retrospective Study
    Yoo, Ji Geun
    Kim, Jin Hwi
    Kim, Chan Joo
    Lee, Hae Nam
    Song, Min Jong
    Park, Dong Choon
    Yoon, Joo Hee
    Kim, Sang Il
    Hur, Soo Young
    Lee, Sung Jong
    [J]. CANCER CONTROL, 2022, 29
  • [28] A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer:: Final results
    Rouëssé, J
    De la Lande, B
    Bertheault-Cvitkovic, F
    Serin, D
    Graïc, Y
    Combe, M
    Leduc, B
    Lucas, V
    Demange, L
    Nguyen, TD
    Castèra, D
    Krzisch, C
    Villet, R
    Mouret-Fourme, E
    Garbay, JR
    Noguès, C
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (04): : 1072 - 1080
  • [29] Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR Trial
    Midgley, Rachel S.
    McConkey, Christopher C.
    Johnstone, Elaine C.
    Dunn, Janet A.
    Smith, Justine L.
    Grumett, Simon A.
    Julier, Patrick
    Iveson, Claire
    Yanagisawa, Yoko
    Warren, Bryan
    Langman, Michael J.
    Kerr, David J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (30) : 4575 - 4580
  • [30] S-1 Based Doublet as ab Adjuvant Chemotherapy for Curatively Open Access Resected Stage III Gastric Cancer: Results from Randomized Phase III POST Trial
    Lee, Choong-Kun
    Jung, Minkyu
    Kim, Hyo Song
    Jung, Inkyung
    Shin, Dong Bok
    Kang, Seok Yun
    Zang, Dae Young
    Kim, Ki Hyang
    Lee, Moon Flee
    Kim, Bong-Seog
    Lee, Kyung Hee
    Cheong, Jae-Ho
    Hyung, Woo Jin
    Noh, Sung Noon
    Chung, Hyun Cheol
    Rha, Sun Young
    [J]. CANCER RESEARCH AND TREATMENT, 2019, 51 (01): : 1 - 11
12345